Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

US Patent 9458112 · Granted Oct 4, 2016

Estimated economic value: $7,016,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Long non-coding RNAS (LNCRNAS) for the diagnosis and therapeutics of brain disor2025
Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibit2025
Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors2024
Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors2024
Bicyclic compounds and their uses2024
Non-coding RNAS (NCRNA) for the diagnosis of cognitive disorders2023
Formylated N-heterocyclic derivatives as FGFR4 inhibitors2020
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors2019
Heterocyclyl-substituted cyclohexylsulfonamides as JAK inhibitors2019
Oxazolidin-2-one-pyrimidine derivatives and the use thereof as phosphatidylinosi2019
Formylated N-heterocyclic derivatives as FGFR4 inhibitors2019
Pharmaceutical combinations2018